{"filing":{"accession_number":"0001213900-26-068774","cik":"0001359931","ticker":"TARA","company_name":"Protara Therapeutics, Inc.","form":"8-K","filing_date":"2026-06-15","report_date":null,"primary_document":"ea0294030-8k_protara.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390026068774/ea0294030-8k_protara.htm"},"events":[{"id":11007,"run_id":9646,"accession_number":"0001213900-26-068774","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a classic Item 5.07 disclosure reporting the results of Protara Therapeutics' Annual Meeting of Stockholders held on June 12, 2026. The filing presents voting results for seven proposals including director elections, auditor ratification, executive compensation approval, equity plan amendment, and charter amendments. Shareholder vote results are material to investors as they reflect stockholder approval of governance and compensation matters.","company_name":"Protara Therapeutics, Inc.","ticker":"TARA","filing_date":"2026-06-15","form":"8-K","submitted_at":null,"items":[{"id":7477,"accession_number":"0001213900-26-068774","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure reporting the results of Protara Therapeutics' Annual Meeting of Stockholders held on June 12, 2026. The filing presents voting results for seven proposals including director elections, auditor ratification, executive compensation approval, equity plan amendment, and charter amendments. Shareholder vote results are material to investors as they reflect stockholder approval of governance and compensation matters.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-15T20:08:10.031985+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":7477,"accession_number":"0001213900-26-068774","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure reporting the results of Protara Therapeutics' Annual Meeting of Stockholders held on June 12, 2026. The filing presents voting results for seven proposals including director elections, auditor ratification, executive compensation approval, equity plan amendment, and charter amendments. Shareholder vote results are material to investors as they reflect stockholder approval of governance and compensation matters.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-15T20:08:10.031985+00:00","company_name":"Protara Therapeutics, Inc.","ticker":"TARA","filing_date":"2026-06-15"}]}